Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report

HR Collard, CJ Ryerson, TJ Corte… - American journal of …, 2016 - atsjournals.org
Acute exacerbation of idiopathic pulmonary fibrosis has been defined as an acute, clinically
significant, respiratory deterioration of unidentifiable cause. The objective of this …

Palliative care in interstitial lung disease: living well

M Kreuter, E Bendstrup, AM Russell… - The Lancet …, 2017 - thelancet.com
Progressive fibrotic interstitial lung diseases (ILDs) are characterised by major reductions in
quality of life and survival and have similarities to certain malignancies. However, palliative …

Diagnosis of hypersensitivity pneumonitis in adults: an official ATS/JRS/ALAT clinical practice guideline

G Raghu, M Remy-Jardin, CJ Ryerson… - American journal of …, 2020 - atsjournals.org
Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It
represents a collaborative effort among the American Thoracic Society, Japanese …

Interstitial lung disease in systemic sclerosis: a simple staging system

NSL Goh, SR Desai, S Veeraraghavan… - American journal of …, 2008 - atsjournals.org
Rationale: In interstitial lung disease complicating systemic sclerosis (SSc-ILD), the optimal
prognostic use of baseline pulmonary function tests (PFTs) and high-resolution computed …

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

A Fischer, KM Antoniou, KK Brown… - European …, 2015 - Eur Respiratory Soc
Many patients with an idiopathic interstitial pneumonia (IIP) have clinical features that
suggest an underlying autoimmune process but do not meet established criteria for a …

[HTML][HTML] Machine learning in radiology: the new frontier in interstitial lung diseases

H Barnes, SM Humphries, PM George… - The Lancet Digital …, 2023 - thelancet.com
Challenges for the effective management of interstitial lung diseases (ILDs) include
difficulties with the early detection of disease, accurate prognostication with baseline data …

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial

TM Maher, TJ Corte, A Fischer, M Kreuter… - The lancet Respiratory …, 2020 - thelancet.com
Background At present, no approved pharmacotherapies are available for unclassifiable
interstitial lung disease (ILD), which is characterised by progressive fibrosis of the lung. We …

Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study

LK Troy, C Grainge, TJ Corte, JP Williamson… - The lancet Respiratory …, 2020 - thelancet.com
Background Transbronchial lung cryobiopsy (TBLC) is a novel technique for sampling lung
tissue for interstitial lung disease diagnosis. The aim of this study was to establish the …

Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia

TJ Corte, GJ Keir, K Dimopoulos, L Howard… - American journal of …, 2014 - atsjournals.org
Rationale: Pulmonary hypertension (PH) associated with fibrotic idiopathic interstitial
pneumonia (IIP; idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia) …

Significance of connective tissue disease features in idiopathic interstitial pneumonia

TJ Corte, SJ Copley, SR Desai… - European …, 2012 - Eur Respiratory Soc
In idiopathic interstitial pneumonia (IIP), the significance of connective tissue disease (CTD)
features in the absence of a specific CTD diagnosis remains unclear. We studied the clinical …